Mission Statement

"Technoclone´s mission is to provide our customers with quality test systems for in vitro diagnostics with special emphasis on the area of Thrombosis and Cardio-vascular diseases."

Prof. Bernd Binder *1945 - U2010


About the Company

... our quality is your success!

Technoclone was founded in 1987 by Prof. Dr. Bernd Binder. The main focus of the company was on monoclonal antibodies against components of the coagulation and the fibrinolytic systems. Technoclone was worldwide the first company offering a complete set of ELISAs and of a novel patented system allowing determination of activity and antigen in the same sample (Actibindâ) in the field of fibrinolysis.

Acquisition of the former Immuno diagnostics portfolio from the Baxter AG.

From 1998 on Technoclone expanded rapidly through the acquisition of the former Immuno diagnostics from Baxter AG and the establishment of an own distribution system in Austria, Germany, the UK and Eastern Europe as well through distributors all over the world.

Production and OEM Products

Today, Technoclone is a world leading producer not only of ELISA systems but also of global and special coagulation tests, control and reference plasmas and protein and lipid diagnostics.

With Ceveron® alpha (, a fully automated coagulation analyzer, the portfolio has been completed. Ceveron® alpha is not only a coagulation analyzer for clotting, photometric and immunological, latex based coagulation tests but also offers the unique feature of fluorimetric measurement in the routine as it is demanded for Technothrombin® TGA a new Thrombin generation test for the determination of thrombophilic tendency, the monitoring of FVIII inhibitor bypass therapies and anticoagulation therapies.

Another innovation is the Ceveron® MFU 500, a micro particle filtration unit which can identify micro particles thombogenicity in conjunction with the assay Technothrombin® MP

Technoclone high quality in vitro diagnostics and test systems are sold worldwide not only under the Technoclone label but are also found as OEM products in the catalogues of international diagnostics companies.

Research & Development

The focus of Technoclone´s research and development is in the field of thrombosis and cardiovascular diseases, the world leading cause of mortality and morbidity. Research and development is pursued in Technoclone´s own research division and in close cooperation with Universities and international and national research consortia such as the Fighting Aneurysmal Disease (FAD). Technoclone holds at present more than 10 international patents in the field of diagnosis and therapy of vascular diseases.